Table 2.
Associations between various biomarkers and all-cause death
| Unadjusted model HR (95%CI) | P | Adjusted model HR (95%CI) | P | |
|---|---|---|---|---|
| TyG | 1.10(0.99–1.23) | 0.096 | 1.14(1.00–1.34) | 0.047 |
| TyG ≤ 8.40 | 1(Ref.) | 1(Ref.) | ||
| TyG > 8.40 | 1.05(1.01–1.23) | 0.034 | 1.04(1.00–1.27) | 0.029 |
| TyG-hsCRP | 1.01(1.01–1.02) | 0.001 | 1.01(1.00–1.02) | 0.002 |
| TyG-hsCRP ≤ 11.48 | 1(Ref.) | 1(Ref.) | ||
| TyG-hsCRP > 11.48 | 1.17(1.01–1.35) | 0.035 | 1.18(1.02–1.39) | 0.030 |
| TyG-CRP | 1.12(1.07–1.17) | 0.001 | 1.17(1.12–1.22) | < 0.001 |
| TyG-CRP ≤ 9.40 | 1(Ref.) | 1(Ref.) | ||
| TyG-CRP > 9.40 | 1.17(1.01–1.35) | 0.034 | 1.31(1.09–1.57) | 0.004 |
| CTI | 1.16(1.07–1.26) | < 0.001 | 1.43(1.24–1.65) | < 0.001 |
| CTI ≤ 8.45 | 1(Ref.) | 1(Ref.) | ||
| CTI > 8.45 | 1.21(1.05–1.40) | 0.008 | 1.44(1.20–1.74) | < 0.001 |
Adjusted model was fully adjusted for age, gender, BMI, systolic blood pressure, smoking status, diabetes status, hypertension, dyslipidemia, hemoglobin A1c, estimated glomerular filtration rate, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, use of antidiabetic agents, antihypertensive medication and lipid-lowering medication
TyG Triglyceride-glucose index, hsCRP High-sensitivity C-reactive protein, CRP C-reactive protein, CTI C-reactive protein–triglyceride glucose index, HR Hazard ratio, CI Confidence interval